0001487371-21-000009.txt : 20210122 0001487371-21-000009.hdr.sgml : 20210122 20210122182551 ACCESSION NUMBER: 0001487371-21-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210120 FILED AS OF DATE: 20210122 DATE AS OF CHANGE: 20210122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maderazo Alan Baer CENTRAL INDEX KEY: 0001811984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34753 FILM NUMBER: 21547369 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GenMark Diagnostics, Inc. CENTRAL INDEX KEY: 0001487371 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 272053069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (760) 448-4300 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 wf-form4_161135793753010.xml FORM 4 X0306 4 2021-01-20 0 0001487371 GenMark Diagnostics, Inc. GNMK 0001811984 Maderazo Alan Baer 5964 LA PLACE COURT SAN DIEGO CA 92008 0 1 0 0 VP, Qual, Reg, & Clin Affairs Common Stock 2021-01-20 4 S 0 5000 15 D 225899 D Common Stock 2021-01-21 4 M 0 26825 0 A 252724 D Common Stock 2021-01-21 4 M 0 21694 0 A 274418 D Common Stock 2021-01-21 4 M 0 16666 0 A 291084 D Market Stock Units 0.0 2021-01-21 4 M 0 26825 0 D Common Stock 26825.0 0 D Market Stock Units 0.0 2021-01-21 4 M 0 21694 0 D Common Stock 21694.0 6667 D Market Stock Units 0.0 2021-01-21 4 M 0 16666 0 D Common Stock 16666.0 16667 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 7/28/2020. The MSU's vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person was eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's three-year total Shareholder return, as compared to the Nasdaq Composite Index. The MSU's vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's two-year total Shareholder return, as compared to the Nasdaq Composite Index. Represents the target number of shares which remain subject to the award. The MSU's vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's one-year total Shareholder return, as compared to the Nasdaq Composite Index. /s/ Eric Stier, Attorney-in-fact 2021-01-22